Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 316.41 USD | +0.62% |
|
+4.81% | +4.43% |
| 07-01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 06-03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 8,390 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 2.16% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 7,641 | 7,424 | 7,283 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | -2.97% | -2.83% | -1.9% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 37.8x | 37x | 37.2x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | 1.22x | 1.17x | - |
| PEG | - | - | - | -0x | -0x | -0.5x | 16.2x | -52.76x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.27x | 3.18x | 3.14x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 2.98x | 2.82x | 2.72x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 19.2x | 17.4x | 16.5x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 28.6x | 24.9x | 22.6x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 24.5x | 23.7x | 22.3x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 4.08% | 4.23% | 4.47% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,567 | 2,635 | 2,676 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 398.6 | 426.3 | 442.3 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 266.8 | 298 | 322 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 314.46 | 314.46 | 314.46 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,762 | - | - |
| Announcement Date | 2/10/22 A | 2/16/23 A | 2/15/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 37.8x | 2.98x | 19.17x | -.--% | 8.39B | |
| 29.22x | 4.03x | 15.68x | 2.51% | 180B | |
| 18.88x | 3.31x | 11.63x | 3.57% | 107B | |
| 17.24x | 0.19x | 12.17x | 0.77% | 60.29B | |
| 30.98x | 7.52x | 19.65x | 1.29% | 50.19B | |
| 38.96x | 3.1x | 10.58x | 2.46% | 43.08B | |
| 37.15x | 1.36x | 11.97x | 0.26% | 32.77B | |
| 29.08x | 5.2x | 16.59x | -.--% | 27.61B | |
| 38.27x | 6.7x | 24x | 0.28% | 23.1B | |
| 23.57x | 3.45x | 12.39x | 1.23% | 20.86B | |
| Average | 30.11x | 3.78x | 15.38x | 1.24% | 55.23B | |
| Weighted average by Cap. | 27.60x | 3.69x | 14.58x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
